Aphena Pharma Solutions, Inc.
Follow
Related Content
-
Breaking News | cGMP Manufacture | Industry News
Aphena Pharma Completes $7M Facility Expansion
Newly renovated, 30,000-sq.-ft. facility and three large blending suites support liquids, creams, gels and suspensions.Cntract Pharma Staff 10.28.20
-
Breaking News | CRO News | Promotions & Moves
Parexel Adds Experts to Regulatory Consulting Group
Four new hires from U.S. FDA and MHRA will serve as technical vice presidents12.10.19
-
Breaking News | Drug Development | Trials & Filings
SK Bio Gains FDA Approval for XCOPRI
Marks the first time a Korean company has independently brought a compound from discovery to U.S. FDA approval11.25.19
-
Biologics, Proteins, Vaccines | Biosimilars
Biopharma Over 20 Years
A look at the key trends that have impacted the biopharma industry over the years.K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19
-
Reader Showcase
Shimadzu Introduces Nexera Preparative SFC System
Next-gen prep SFC system designed to provide the pharma industry with reliable high-performance semi-prep purification11.15.19
-
Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future
Tuesday, November 5th, 1:30 PM - 2:30 PM Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future Location: 214 CD Manufacturing and Bioprocessing – Chemical…10.28.19
-
Drug Development | Information Technology
Will Artificial Intelligence Revolutionize Pharma?
Bloomberg Intelligence's Elizabeth Krutoholow discusses whether pharma is ready for an AI revolution
-
Clinical Trials | Serialization | Supply Chain
Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution
Keeping up with counterfeitors in the pharmaceutical industry is no easy task, but patients’ lives depend on it.Ben Locwin, Healthcare Science Advisors 10.04.19
-
Breaking News | Facilities | Industry News
NextPharma Completes Acquisition of Santen’s Tampere Manufacturing Facility
Bolsters position in the pharmaceutical industry in Finland10.02.19
-
Breaking News | Industry News
Colorcon Launches $50M Venture Capital Fund
Pharmaceutical leader partners with Touchdown Ventures to fund promising startups09.18.19
-
Contracting And Outsourcing Exhibitor List
2019 Exhibitors Company Table 3C PACKAGING 138 Adare Pharmaceuticals 97 Adents 123 Admix Pharma Labs 135 Advanced Analytical…09.17.19
-
Regulatory Affairs
Quality Metrics Feedback
A look at FDA’s Quality Metrics Initiative, a complicated issue for all of pharma stakeholdersGil Roth, President, Pharma & Biopharma Outsourcing Association 09.16.19
-
Breaking News | Clinical Trials | Industry News | Inspections | QA/QC
FDA Extends CRADA with CluePoints
Aims to further explore a data-driven approach to quality oversight in clinical trials09.11.19
-
Tergus Pharma
Tergus is a full-service topical pharmaceutical research, development, testing and commercial manufacturing company.09.10.19
-
cGMP Manufacture | Collaborations & Alliances
NIIMBL, FDA to Advance Innovation in Bio Manufacturing
CRADA enables FDA and NIIMBL to support investments in regulatory science research, and training needed to foster advanced manufacturing innovations08.01.19
-
Trials & Filings
FDA Accepts RedHill Biopharma’s NDA for Talicia
Commercial launch of H. pylori treatment is planned shortly following potential FDA approval07.16.19
-
Extractables and Leachables | Laboratory Testing
The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?
Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standardsKristin Brooks, Contract Pharma 07.11.19
-
Trials & Filings
Sierra’s Momelotinib Granted FDA Fast Track Designation
Underscores potential for momelotinib to address unmet needs of patients with Intermediate/High-Risk myelofibrosis who have previously received a JAK inhibitor06.19.19
